Most Recent Additions*
The Pediatrician's Role in Eliminating Racial and Ethnic Disparities in Sleep-Related Infant Deaths.
Jeffrey D. Colvin and Rachel Y. Moon
Infant Deaths in Sitting Devices.
Peter Liaw, Rachel Y. Moon, Autumn Han, and Jeffrey D. Colvin
Invasive Bacterial Infections in Infants Younger Than 60 Days With Skin and Soft Tissue Infections.
Dana M. Foradori, Michelle A. Lopez, Matt Hall, Andrea T. Cruz, Jessica L. Markham, Jeffrey D. Colvin, Jennifer A. Nead, Mary Ann Queen, Jean L. Raphael, and Sowdhamini S. Wallace
The Effect of Lowering Public Insurance Income Limits on Hospitalizations for Low-Income Children.
Jessica L. Bettenhausen, Matt Hall, Jeffrey D. Colvin, Henry T. Puls, and Paul J. Chung
Atorvastatin may have no effect on acute phase reaction in children after intravenous bisphosphonate infusion.
Tarak Srivastava, Connie J. Haney, and Uri S. Alon
Impact of standardization of creatinine methodology on the assessment of glomerular filtration rate in children.
Tarak Srivastava, Uri S. Alon, Randah Althahabi, and Uttam Garg
Pathophysiology of hypercalciuria in children.
Tarak Srivastava and Uri S. Alon
Use of the multipurpose drainage catheter for the provision of acute peritoneal dialysis in infants and children.
Ari Auron, Bradley A. Warady, Steve Simon, Douglas Blowey, Tarak Srivastava, Gulam Musharaf, and Uri S. Alon
Measurement of urea nitrogen and creatinine concentrations in peritoneal dialysate and other body fluids using the Vitros analyzer.
Tarak Srivastava, Randah Althahabi, and Uttam Garg
Essentials of laboratory medicine for the nephrology clinician.
Tarak Srivastava, Uttam Garg, Y Raymond Chan, and Uri S. Alon
Sustained beneficial effect of intravenous bisphosphonates after their discontinuation in children.
Kim M. Waterhouse, Ari Auron, Tarak Srivastava, Connie J. Haney, and Uri S. Alon
Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
Tarak Srivastava, Robert E. Garola, and H K. Singh
Recurrence of proteinuria following renal transplantation in congenital nephrotic syndrome of the Finnish type.
Tarak Srivastava, Robert E. Garola, Marjo Kestila, Karl Tryggvason, Vesa Ruotsalainen, Mukut Sharma, Virginia J. Savin, Hannu Jalanko, and Bradley A. Warady
Nondiabetic consequences of obesity on kidney.
Tarak Srivastava
Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study.
Rima S. Zahr, Marianne E. Yee, Jack Weaver, Katherine Twombley, Raed Bou Matar, Diego Aviles, Rajasree Sreedharan, Michelle N. Rheault, Rossana Malatesta-Muncher, Hillarey Stone, Tarak Srivastava, Gaurav Kapur, Poornima Baddi, Oded Volovelsky, Jonathan Pelletier, Rasheed Gbadegesin, Wacharee Seeherunvong, Hiren P. Patel, and Larry A. Greenbaum
Use of calcimimetics in children with normal kidney function.
Judith Sebestyen VanSickle, Tarak Srivastava, and Uri S. Alon
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
Laura H. Mariani, Andrew S. Bomback, Pietro A. Canetta, Michael F. Flessner, Margaret Helmuth, Michelle A. Hladunewich, Jonathan J. Hogan, Krzysztof Kiryluk, Patrick H. Nachman, Cynthia C. Nast, Michelle N. Rheault, Dana V. Rizk, Howard Trachtman, Scott E. Wenderfer, Corinna Bowers, Peg Hill-Callahan, Maddalena Marasa, Caroline J. Poulton, Adelaide Revell, Suzanne Vento, Laura Barisoni, Dan Cattran, Vivette D'Agati, J Charles Jennette, Jon B. Klein, Louis-Philippe Laurin, Katherine Twombley, Ronald J. Falk, Ali G. Gharavi, Brenda W. Gillespie, Debbie S. Gipson, Larry A. Greenbaum, Lawrence B. Holzman, Matthias Kretzler, Bruce Robinson, William E. Smoyer, Lisa M. Guay-Woodford, CureGN Consortium, and Tarak Srivastava
Adrenocorticotropic Hormone for Childhood Nephrotic Syndrome: The ATLANTIS Randomized Trial.
Chia-Shi Wang, Curtis Travers, Courtney McCracken, Traci Leong, Rasheed Gbadegesin, Alejandro Quiroga, Mark R. Benfield, Guillermo Hidalgo, Tarak Srivastava, Megan Lo, Ora Yadin, Robert Mathias, Carlos E. Araya, Myda Khalid, Alvaro Orjuela, Joshua Zaritsky, Samhar Al-Akash, Margret Kamel, and Larry A. Greenbaum
Risk Factors for Short- and Long-Term Outcomes in Children With STEC-HUS/D
Judith Sebestyen VanSickle, Tarak Srivastava, and Uri S. Alon
DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS.
Howard Trachtman, Peter Nelson, Sharon Adler, Kirk N. Campbell, Abanti Chaudhuri, Vimal Kumar Derebail, Giovanni Gambaro, Loreto Gesualdo, Debbie S. Gipson, Jonathan Hogan, Kenneth Lieberman, Brad Marder, Kevin Edward Meyers, Esmat Mustafa, Jai Radhakrishnan, Tarak Srivastava, Miganush Stepanians, Vladimír Tesar, Olga Zhdanova, Radko Komers, and DUET Study Group
*Updated as of 12/12/19.
